GlassScriptPhysician profile
David Lamar Spencer
NPI 1386842755
$4,041.82
in general payments reported to CMS, 2019-2025
41 companies · $738 in 2025
The $738 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $77.77 · 2021: $154 · 2022: $662 · 2023: $506 · 2024: $1,446 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,553 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.39 |
| Education | $136.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $943.60 | 2022-2025 | Erleada, Akeega, Balversa |
| Tolmar Pharmaceuticals, INC. | $497.60 | 2020-2022 | |
| Astellas Pharma US INC | $406.11 | 2019-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $261.27 | 2024-2025 | Provenge |
| Pfizer INC. | $173.35 | 2019-2025 | |
| Boston Scientific Corporation | $172.19 | 2021-2023 | |
| Urogen Pharma, INC. | $167.54 | 2021-2025 | |
| Medtronic, INC. | $118.71 | 2023-2024 | Interstim |
| Stryker Corporation | $105.87 | 2023 | N/A |
| Coloplast Corp | $91.32 | 2019-2024 | |
| Endo USA, INC. | $86.96 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $85.29 | 2022-2024 | Xiaflex, Aveed, Edex |
| Covidien LP | $82.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.05 | 2020-2025 | |
| Progenics Pharmaceuticals, INC. | $70.99 | 2022-2024 |
Show all 40 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$14,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spencer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.